GeneThera Inc (GTHR)
OTHER OTC:GTHR
US Market
Holding GTHR?
Track your performance easily

GeneThera (GTHR) Income Statement

1 Followers

GeneThera Income Statement

Last quarter (Q ), GeneThera's total revenue was $―, a decrease of ― from the same quarter last year. In Q, GeneThera's net income was $-125.57K. See GeneThera’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
------
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 681.22K$ 1.01M$ 740.61K$ 1.21M$ 4.04M$ 945.00K
Operating Income
$ -680.11K$ -1.01M$ -740.61K$ -1.21M$ -4.04M$ -945.00K
Net Non Operating Interest Income Expense
$ 243.82K$ -2.22K$ -33.85K$ -28.58K$ 530.38K$ -146.62K
Other Income Expense
-----$ 5.40K
Pretax Income
$ -681.26K$ -1.01M$ -774.46K$ -1.24M$ -3.51M$ -1.10M
Tax Provision
----$ -34.52K$ -35.08K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -436.29K$ -1.01M$ -774.46K$ -1.24M$ -3.51M$ -1.10M
Basic EPS
$ -0.04$ -0.04$ -0.04---
Diluted EPS
$ -0.04$ -0.04$ -0.04---
Basic Average Shares
$ 25.35M$ 25.35M$ 20.31M$ 35.90M$ 3.90M$ 40.06M
Diluted Average Shares
$ 25.35M$ 25.35M$ 20.31M$ 35.90M$ 3.90M$ 40.06M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 681.22K$ 1.01M$ 740.61K$ 1.21M$ 4.04M$ 945.00K
Net Income From Continuing And Discontinued Operation
$ -681.26K$ -1.01M$ -774.46K$ -1.24M$ -3.51M$ -1.10M
Normalized Income
------
Interest Expense
------
EBIT
$ -679.57K$ -1.01M$ -740.61K$ -1.21M$ -3.40M$ -950.40K
EBITDA
$ -674.29K$ -1.00M$ -735.33K$ -1.21M$ -3.39M$ -950.40K
Currency in USD

GeneThera Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis